Skip to main content
Official Logo of Columbia Business School
Academics
  • Visit Academics
  • Degree Programs
  • Admissions
  • Tuition & Financial Aid
  • Campus Life
  • Career Management
Faculty & Research
  • Visit Faculty & Research
  • Academic Divisions
  • Search the Directory
  • Research
  • Faculty Resources
  • Teaching Excellence
Executive Education
  • Visit Executive Education
  • For Organizations
  • For Individuals
  • Program Finder
  • Online Programs
  • Certificates
About Us
  • Visit About Us
  • CBS Directory
  • Events Calendar
  • Leadership
  • Our History
  • The CBS Experience
  • Newsroom
Alumni
  • Visit Alumni
  • Update Your Information
  • Lifetime Network
  • Alumni Benefits
  • Alumni Career Management
  • Women's Circle
  • Alumni Clubs
Insights
  • Visit Insights
  • Digital Future
  • Climate
  • Business & Society
  • Entrepreneurship
  • 21st Century Finance
  • Magazine

Vaccines for Kids Linked to Economic Growth

A new study led by Neal Masia, Vice President of Patient & Health Impact at Pfizer, and Adjunct Professor of Business in the Management Division at Columbia Business School in New York, assessed how changes in childhood vaccine investment impact a country's gross domestic product (GDP). Using the DTP (diphtheria, tetanus and pertussis) as a proxy for vaccination programs generally, the research findings show that improved childhood vaccination rates were associated with economic growth, suggesting a significant and long-term increases in the GDP growth rate.
Published
May 2, 2018
Publication
CBS Newsroom
Jump to main content
News Type(s)
Healthcare Program
Topic(s)
Business Economics and Public Policy, Healthcare

0%

Vaccines Can Help People Live Healthier, More Productive Lives- And, According To New Research, They Can Help Make A Country's Economy Healthier And More Productive Too. A new study led by Neal Masia, Vice President of Patient & Health Impact at Pfizer, and Adjunct Professor of Business in the Management Division at Columbia Business School in New York, assessed how changes in childhood vaccine investment impact a country’s gross domestic product (GDP). Using the DTP (diphtheria, tetanus and pertussis) as a proxy for vaccinations programs generally, the research findings show that improved childhood vaccination rates were associated with economic growth, suggesting significant and long-term increases in the GDP growth rate. In fact, improving a country’s childhood vaccination rate by even a mere 1% was found to show measurable improvement in economic growth. "Vaccination rates vary significantly across countries and the strength of vaccination programs is a matter of public choice, infrastructure limitations, budget constraints, and many other factors – and up until now there has been little research to help facilitate a conversation between Health Ministers and Finance Ministers about difficult investment tradeoffs," said Masia. "We pursued this research to help frame the decision about how much to invest in childhood vaccination programs generally in a growing, middle-income country. The economically meaningful and seemingly long-lasting effect of vaccines on economic growth suggests an enhanced case for prioritizing and maintaining vaccination programs."
Save Article

Download PDF

Share
  • Share on Facebook
  • Share on Threads
  • Share on LinkedIn

External CSS

Official Logo of Columbia Business School

Columbia University in the City of New York
665 West 130th Street, New York, NY 10027
Tel. 212-854-1100

Maps and Directions
    • Centers & Programs
    • Current Students
    • Corporate
    • Directory
    • Support Us
    • Recruiters & Partners
    • Faculty & Staff
    • Newsroom
    • Careers
    • Contact Us
    • Accessibility
    • Privacy & Policy Statements
Back to Top Upward arrow
TOP

© Columbia University

  • X
  • Instagram
  • Facebook
  • YouTube
  • LinkedIn